Nutrien Ltd vs TransMedics Group Inc — how do they compare? Nutrien Ltd trades at $66.8 (market cap $31.67B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Nutrien Ltd is far larger — about 12.5× TransMedics Group Inc's market cap, and Nutrien Ltd pays a 3.3% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NTR | TMDX | |
|---|---|---|
Market Cap | $31.67B | $2.54B |
Sector | Basic Materials | Technology |
52-Week High | $83.94 | $150.42 |
52-Week Low | $53.64 | $61.99 |
Enterprise Value | $44.84B | $2.94B |
Dividend Yield | 3.3% | — |
Signals from Pluang's Aura AI — not financial advice
Nutrien (NTR) trades at $66.84, down 0.65% with neutral technical signals. The company shows improving fundamentals with Q1 2026 earnings beat and projected revenue growth to $27.8B in 2026. Valuation appears reasonable with P/E of 13.58 and P/S of 1.16. Recent institutional buying activity and a $0.55 dividend payment scheduled for July 2026 provide additional investor appeal.
The outlook remains positive with strong analyst consensus (60.6% buy ratings) and $77.67 price target suggesting 16% upside. Key risks include volatile input costs and fertilizer market dynamics. The combination of reasonable valuation, earnings momentum, and institutional support positions NTR favorably for long-term investors despite near-term market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →